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Introduction: Severe dengue hemorrhagic fever (DHF) is a viral infection that acts to
increase permeability of capillaries, resulting in internal hemorrhage. Linear frequency
domain Fourier spectral analysis represents the most published noninvasive tool for
diagnosing and assessing health status via calculated heart rate variability (HRV). As
such, HRV may be useful in assessing clinical status in DHF patients, but is prone to
erroneous results and conclusions due to the influence of the average HR during the time
period of HRV assessment (defined as the “prevailing” HR). We tested the hypothesis
that alterations in HRV calculated with linear frequency analysis would be minimal when
mathematically corrected for prevailing HR following dengue viral infection.
Methods: Male (N = 16) and female (N = 11) patients between the ages of 6 months
and 15 years of age (10 ± 6 SD years) were tracked through the progression of the
dengue viral infection with treatment following the abatement of a fever (defervescence).
Electrocardiographic recordings were collected and analyzed for HRV.
Results: High frequency (HF), low frequency (LF), and LF/HF ratio were unaffected by
correction for prevailing HR.
Conclusion: HRV corrected for changes in HR did not alter the interpretation of our data.
Therefore, we conclude that cardiac parasympathetic activity (based on HF frequency) is
responsible for the majority of the HR reduction following defervescence in patients with
dengue viral infection.
Keywords: dengue hemorrhagic fever, heart rate variability, high power frequency, parasympathetic nervous
system, autonomic balance
INTRODUCTION
Heart rate variability (HRV) represents a noninvasive “vital sign”
that can be easily calculated in real-time from the R-to-R interval
of the electrocardiogram (ECG). Low HRV has been recognized
as reflecting more severe pathophysiology as reported in ICU
patients (Winchell and Hoyt, 1996; Grogan et al., 2005; Morris
et al., 2006; Norris et al., 2008; Ryan et al., 2008), experimental
human models of hemorrhage (Convertino et al., 2008; Cooke
et al., 2008; Ryan et al., 2010), and following injury in trauma
(Cooke et al., 2006a,b; Cancio et al., 2008; Ong et al., 2008; King
et al., 2009), while high HRV has been used as an indication
of improved health. However, these reported results were based
on linear analyses of HR calculated in the time and frequency
domains. Importantly, linear frequency analysis of HRV is signif-
icantly affected by both physiological and mathematical factors
as a result of the nonlinear relationship between R -R intervals
and HR (Sacha and Pluta, 2005). As such, the use of HRV met-
rics to provide an accurate assessment of the effectiveness in the
treatment of hemorrhage relies on the assumption that the math-
ematical influence of is the average HR during the time period
of HRV assessment [defined as the “prevailing” HR] on HRV is
not present or has been corrected. This assumption is reason-
able when HR is not different between clinical populations of
comparison or over time in the same patient population. But in
the absence of mathematical adjustment of differences in HR by
dividing R-R intervals by the corresponding average R-R, accurate
interpretation of changes in HRV may be severely compromised
(Sacha and Pluta, 2005, 2008; Billman, 2011, 2013b; Sacha, 2013;
Sacha et al., 2013a,b).
Severe dengue hemorrhagic fever (DHF) is a viral infec-
tion that acts to increase permeability of capillaries, resulting in
internal hemorrhage. The diagnosis and management of dengue
vascular permeability syndrome has been one of the greatest
challenges over the past fifty plus years since dengue shock syn-
drome was first described (Cohen and Halstead, 1966; Halstead
et al., 1970). Since HR decreases from the time of patient hospital
admission to the time of discharge (Yacoub et al., 2012), we con-
sidered the potential use of HRVwith confounding changes inHR
as an opportunity to determine the usefulness of HRV to assess
the effectiveness of in-hospital treatment and to provide clearer
insight into the physiology underlying the association of changes
in HR with the recovery from DHF.
In the present investigation, we had the unique opportunity
to monitor R-to-R interval measurements from patients with
dengue viral infection during their hospitalization in order to
capture HRV during the progression of the disease and treatment
following the day of the abatement of a fever (defervescence). This
approach provided the opportunity to assess the mathematical
www.frontiersin.org February 2014 | Volume 5 | Article 46 | 1
Carter et al. HRV in patients with dengue
influence of HR on HRV in a patient population with inter-
nal hemorrhage by comparing linear measures of HRV with and
without mathematical correction as a potential indicator of the
effectiveness of treatment. Although Sacha and co-workers (Sacha
and Pluta, 2005, 2008; Sacha et al., 2013b) have recently exam-
ined the relationship between average HR and indices of HRV
under baseline conditions and comparedmethods to correct HRV
for HR, the effects of HR on HRV during dengue fever (DF)
disease progression and treatment remained to be determined.
We hypothesized that alterations in HRV calculated with lin-
ear frequency analysis would be minimal or eliminated when
mathematically corrected for changing HR under these unique
conditions.
MATERIALS AND METHODS
Male (N = 16) and (N = 11) female patients between the ages
of 6 months and 15 years of age (10 ± 6 SD years) who were
admitted to the Queen Sirikit National Institute of Child Health
(QSNICH) with fever and suspected dengue were eligible for
enrollment. Exclusion criteria for the study included known
chronic conditions (e.g., liver and renal disease, malignancy,
thalassemia). Informed consent from a parent or guardian was
provided for all study procedures. The study was approved by the
hospital Institutional Review Board, the Thai Ministry of Public
Health, the US Army Surgeon General, and the University of
Massachusetts Medical School. In order to track the progression
of the dengue viral infection with treatment following deferves-
cence, we used data collected on days 0 (defervescence), 1, and
2. Day 0 ranged from 0 to 3 days (mean 1 ± 0.9 SD days) fol-
lowing admission to the hospital. All data used in this study were
collected in the morning (07.00–10.00) while patients were in the
supine position (i.e., hospital bed).
Electrocardiographic recordings were collected in using a
Nexfin (BMEye, Amsterdam, the Netherlands) at a sampling rate
of 1000Hz and exported at a rate of 200Hz to a computer-based
data acquisition software package (WinDAQ, Dataq Instruments,
Akron, OH). The ECG waveforms were imported into data anal-
ysis software (WinCPRS, Absolute Aliens, Turku, Finland) using
a Labview application for automatic R-wave detection. Due to the
200-Hz sampling rate, a smoothing filter of a 5-point running
average was applied to the ECG data to provide clear peaks for
R-wave generation. This filter application produced 0.5–1.0 s of
data to be cut from each of the ECG waveforms. All signals were
manually scanned for noise and missing R-wave detection. ECG
recordings were discarded if they contained less than five minutes
of data, more than one ectopic beat during any 5-min time span,
or contained electromechanical noise or interference. Aberrant
beats in the ECG recording were interpolated, most occurring
from calibration or patient movement.
HRV measurements were assessed with analysis of R-R inter-
vals (the time between the two successive R waves in ECG)
using frequency domain methods obtained from 300-s con-
tinuous recordings with the least amount of aberrant beats.
Using WinCPRS software, the following metrics were obtained
according to a previously described approach (Ryan et al., 2010)
RRI, heart rate (HR), RRI low frequency power (LF), RRI high
frequency power (HF), and LF/HF ratio. However, HRVmeasure-
ments have been shown to be significantly associated with HR
due to both physiological and mathematical reasons. In order to
remove mathematical bias from our HRV calculations, we used
the HR correction methodology previously described by Sacha
et al.(Sacha and Pluta, 2005; Sacha, 2013; Sacha et al., 2013a).
Removal of this mathematical bias was achieved by the divi-
sion of the SD of R-R interval (RRSD) by average R-R interval
and HRV indices (LF and HF) by the average R-R interval (in
seconds) squared. Corrected LF/HF ratio was calculated from
corrected LF and corrected HF. After this initial mathematical
correction was made, the relationships between resting HR and
HRV indices (SD of R-R interval, LF variability, and HF vari-
ability) were evaluated by linear regression analysis. The resulting
coefficient of determination (r2) value (i.e., r2 = 0.38) from the
regression analysis was interpreted as the% change in HRV due to
the prevailing HR. All reported coefficients of determination cor-
respond to the RRSD/HR relationship. Therefore, comparison of
r2-values before and after mathematical correction for prevailing
HR, allowed for tracking of how prevailing HR influenced HRV
during dengue viral infection. All data are presented as mean ±
SD. An ANOVA with repeated measures was used for comparison
between fever days.
RESULTS
The comparison of corrected and uncorrected HRV parameters
following defervescence is presented in Table 1. By day 2, HR
decreased from 98 ± 12 to 81 ± 9 beats per minute and RRI
increased from 623 ± 73 to 750 ± 78ms. Uncorrected HF and
LF variability increased on Day 2 while LF/HF ratio decreased
(P < 0.001). After correction for prevailing HR, corrected HF
and LF variability were still increased, and LF/HF ratio was still
decreased (P < 0.001) each of the 2 days following defervescence
(Table 1). At defervescence (Day 0), HR accounted for ∼40%
(r2 = 0.38) of the variability (based on RRSD/HR relationship)
before correction for HR and ∼30% (r2 = 0.28) of the vari-
ability after correction for HR (normalized unit following HR
correction). By Day 2 prevailing HR accounted for ∼7% prior to
application of HR correction and less than 1% after correction.
To compare the absolute changes in HRV between Day 0
and Days 1 and 2 in a quantitative fashion, changes in HRV
indices were calculated as percent changes (Table 2). Application
of HR correction did not influence the interpretation of HF, LF,
and LF/HF ratio on days 1 and 2. Specifically, uncorrected HF
increased by 424 ± 120% and corrected HF increased by 377 ±
134% on day 2 (p = 0.45). By day 2, uncorrected LF increased by
425 ± 83% and corrected LF increased slightly less to 327 ± 96%
(P < 0.05).
DISCUSSION
In general, alteration in HRV offers a clinically useful and
quantifiable measure of alteration in the physiologic state of the
human body. The most published HRV assessment technique for
diagnosing infection is the frequency domain Fourier spectral
analysis. This method; however, may be prone to erroneous
results and conclusions from data due to the influence of prevail-
ing HR. We demonstrated that the HR correction methodology
used in this study was an effective way to examine HRV alter-
ations and autonomic balance, independent of prevailing HR.
The following indices of HRV were determined: (1) vagal cardiac
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Table 1 | Heart rate variability indices with and without correction for prevailing HR.
Uncorrected RRI (ms) r2 (HR to RRSD) HR (b/min) HF (ms2) LF (ms2) LF/HF
Day 0 623 ± 74 0.38* 98 ± 12 194 ± 495 249 ± 381 8.2 ± 9.6
Day 1 707 ± 86 0.34 87 ± 11 405 ± 571 622 ± 751 4.1 ± 4.5
Day 2 751 ± 78# 0.07# 81 ± 9# 824 ± 1146# 1060 ± 1052# 2.4 ± 2.0#
Corrected r2 (HR to RRSD) HR (b/min) HF LF LF/HF
Day 0 – 0.28 98 ± 12 0.0003 ± 0.0008 0.0005 ± 0.0007 8.2 ± 9.6
Day 1 – 0.19 87 ± 11 0.0007 ± 0.0009 0.001 ± 0.001 4.1 ± 4.5
Day 2 – 0.004# 81 ± 9# 0.0014 ± 0.0019# 0.002 ± 0.001# 2.4 ± 2.0#
*Note that HR accounted for 38% (r2 = 0.38) of the variability before correction for HR and 28% (r2 = 0.28) following HR correction.
#Denotes significant differences between Day 0 and Day 2. Values are presented as mean ± SD.
parasympathetic activity as HF component of R-R interval
variability (HF, 0.15–0.40Hz), (2) LF component (0.04–0.15Hz),
and LF/HF ratio. The interpretation of LF/HF ration as a marker
of autonomic balance has been recently questioned (Billman,
2013a,b) and has been shown to reflect major parasympathetic
activity (∼50%) and some sympathetic activity (Randall et al.,
1991).
The present study investigated the effects of HR responses in
dengue viral infected patients on HRV with and without correc-
tion for the baseline HR. Our major findings are (1) correcting
HRV did not affect the direction of change in HRV parameters
and (2) correcting HRV allowed for more accurate assessment
of possible sympathetic (SNS) and parasympathetic nervous sys-
tems (PSNA) contributions to HRV. While we hypothesized that
alterations in HRV would be minimal when corrected for prevail-
ing HR, our data suggest that there is an autonomic regulatory
basis for the HRV alterations observed with dengue viral infec-
tion independent of the influence of HR. HRV uncorrected and
corrected for changes in HR revealed that cardiac parasympa-
thetic activity likely plays major role of the HR changes following
defervescence.
La-Orkhun et al. (2011) assessed HRV as an index of auto-
nomic function in patients with DF, and found no significant
changes in various time and frequency domain metrics of HRV
at least 24 h after defervescence and follow-up conducted at least
14 days after defervescence. Since monitoring was performed 2
weeks after hospital discharge, it is unlikely that changes in HRV
during the critical phase of illness would have been detected in
their study. As such, we are the first to report HRV analysis in
patients during in- hospital treatment for dengue viral infection
that demonstrated significant reductions in HRV.
Several studies have examined the usefulness of HRV analysis
for early diagnosis and prognosis of viral infections, particu-
larly in neonates and infants at risk of developing septic shock
(Griffin and Moorman, 2001; Griffin et al., 2004, 2005). In their
studies, it was reported that abnormal HR with reduced variabil-
ity and transient decelerations preceded neonatal/infant sepsis.
In a study on 81 patients, Chen and Kuo showed that septic
patients who subsequently developed shock had lower LF/HF
ratio with respect to patients who did not develop sepsis (Chen
and Kuo, 2007). In our study, the LF/HF ratio showed a progres-
sive reduction during recovery from dengue infection (Table 1)
with and without HR correction. While, it has been suggested the
Table 2 | Percent changes in HRV parameters following Day 0
(defervescence) with and without HR correction.
Day 1 Day 2
Uncorrected % Corrected % Uncorrected % Corrected %
HF 209 ± 43 189 ± 76 424 ± 120 377 ± 134
LF 249 ± 90 237 ± 74 425 ± 83 327 ± 96*
LF/HF ratio 50 ± 34 50 ± 34 29 ± 23 29 ± 23
*Denotes significant differences in uncorrected and corrected.
decreases in LF/HF ratio correspond to shift toward parasympa-
thetic dominance (Eckberg, 1997), autonomic balance has been
recently interrogated (Billman, 2013b). These adjustments in
autonomic regulation are consistent with our observations in
the HR response and RRI returning toward baseline values with
in-hospital resuscitative treatment in DHF patients.
After correction for prevailing HR, LF variability was still
significantly increased (both P < 0.01) on day 2 following defer-
vescence. Furthermore, when corrected for prevailing HR, the
percent change in LF variability was slightly reduced from uncor-
rected values of 425% to corrected values of 327%. Houle and
Billman (1999) and co-workers demonstrated that the LF compo-
nent of the HR power spectrum probably results from an interac-
tion of the sympathetic and PSNA and, as such, does not precisely
reveal changes in the sympathetic activity (Randall et al., 1991).
These data further support our interpretation that reductions in
HR following defervescence are mediated by increased cardiac
parasympathetic activity and not reductions in sympathetic drive.
In conclusion, we showed that uncorrected and corrected HRV
does not alter the interpretation of the potential contributions
of parasympathetic and sympathetic activity in patients with
dengue viral infection during their hospitalization. Additionally,
HRV uncorrected and corrected for changes in HR suggest that
cardiac parasympathetic activity plays an important role in HR
changes following defervescence. Furthermore, the HR correc-
tion methodology employed in this study provided a unique
opportunity to delineate the physiological changes in HR during
treatment of dengue viral infection.
DISCLAIMER
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